Role for Krüppel-like factor 4 in determining the outcome of p53 response to DNA damage

Cancer Research

Volumn 69, Issue 21, 2009, Pages 8284-8292

  Qibing, Zhou ^a,b   Yuan, Hong ^b   Qimin, Zhan ^b   Yan, Shen ^a   Zhihua, Liu ^b  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; PROTEIN P53; ELAV-LIKE PROTEIN 1; HUR PROTEIN; KRUPPEL LIKE FACTOR; MEMBRANE ANTIGEN; RNA BINDING PROTEIN; TP53 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL REGENERATION; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; CELL CYCLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; WESTERN BLOTTING;

ANTIGENS, SURFACE; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70350539580     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1345     Document Type: Article

References (45)

1. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001;27:247-254 (Pubitemid 32201842)
2. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000;408:433-439
3. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2:594-604. (Pubitemid 37328926)
4. Aylon Y, Oren M. Living with p53, dying of p53. Cell 2007;130:597-600.
5. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-825
6. 2/M progression. Mol Cell 1997;1:3-11.
7. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-299
8. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001;7:683-694 (Pubitemid 32706359)
9. Villunger A, Michalak EM, Coultas L, et al. p53- and drug-induced apoptotic responses mediated by BH3- only proteins puma and noxa. Science 2003;302:1036-1038 (Pubitemid 37386194)
10. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 2001;8:781-794 (Pubitemid 33030212)
11. Tanaka T, Ohkubo S, Tatsuno I, Prives C. hCAS/ CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell 2007;130:638-650 (Pubitemid 47268061)
12. Wei X, Xu H, Kufe D. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Cancer Res 2007;67:1853-1858 (Pubitemid 46383412)
13. Bernal JA, Luna R, Espina A, et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 2002;32: 306-311
14. Zheng H, You H, Zhou XZ, et al. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002;419:849-853 (Pubitemid 35238572)
15. Zacchi P, Gostissa M, Uchida T, et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002;419:853-857 (Pubitemid 35238573)
16. Das S, Raj L, Zhao B, et al. Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 2007;130:624-637 (Pubitemid 47277418)
17. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem1996;271:20009-20017
18. Segre JA, Bauer C, Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 1999;22:356-360 (Pubitemid 29369526)
19. 1/S progression of the cell cycle. J Biol Chem2001;276:30423-30428
20. Chen X, Whitney EM, Gao SY, Yang VW. Transcriptional profiling of Kruppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J Mol Biol 2003;326:665-677 (Pubitemid 36279310)
21. Zhang W, Geiman DE, Shields JM, et al. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 2000;275:18391-18398 (Pubitemid 30414796)
22. Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 2008;68:4631-4639
23. Shie JL, Chen ZY, Fu M, Pestell RG, Tseng CC. Gut-enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res 2000;28:2969-2976 (Pubitemid 30599273)
24. Foster KW, Ren S, Louro ID, et al. Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ 1999; 10:423-434 (Pubitemid 29284184)
25. Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005;7:1074-1082
26. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318-324
27. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676 (Pubitemid 44233629)
28. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317 (Pubitemid 47080336)
29. 1/S cell cycle arrest in response to DNA damage. J Biol Chem 2003;278:2101-2105
30. 46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007;25:739-750
31. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 2004;23:3092-3102 (Pubitemid 39093603)
32. Shi B, Liang J, Yang X, et al. Integration of estrogen andWnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.Mol Cell Biol 2007;27:5105-5119
33. Kaeser MD, Iggo RD. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci U S A 2002;99:95-100.
34. Lopez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M. Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci U S A 2004;101:2987-2992 (Pubitemid 38327723)
35. Abdelmohsen K, Pullmann R, Jr., Lal A, et al. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 2007;25:543-557 (Pubitemid 46274441)
36. Ghaleb AM, Katz JP, Kaestner KH, Du JX, Yang VW. Kruppel-like factor 4 exhibits antiapoptotic activity following γ-radiation-induced DNA damage. Oncogene 2007;26:2365-2373
37. Luo J, Nikolaev AY, Imai S, et al. Negative control of p53 by Sir2α promotes cell survival under stress. Cell 2001;107:137-148 (Pubitemid 33035941)
38. Moore MJ. Frombirth to death: the complex lives of eukaryotic mRNAs. Science 2005;309:1514-1518
39. Keene JD, Tenenbaum SA. Eukaryotic mRNPsmay represent posttranscriptional operons. Mol Cell 2002;9:1161-1167
40. Garcia-Martinez J, Aranda A, Perez-Ortin JE. Genomic run-on evaluates transcription rates for all yeast genes and identifies gene regulatory mechanisms. Mol Cell 2004;15:303-313 (Pubitemid 38950977)
41. Wilusz CJ, Wilusz J. Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet 2004;20:491-497 (Pubitemid 39201069)
42. Lal A, Kawai T, Yang X, Mazan-Mamczarz K, Gorospe M. Antiapoptotic function of RNA-binding protein HuR effected through prothymosin α. EMBO J 2005;24:1852-1862 (Pubitemid 40769504)
43. Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Life Sci 2001;58:266-277
44. Katsanou V, Papadaki O, Milatos S, et al. HuR as a negative posttranscriptional modulator in inflammation. Mol Cell 2005;19:777-789 (Pubitemid 41316672)
45. Li H, Park S, Kilburn B, et al. Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase. J Biol Chem 2002;277:44623-44630